Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment

The essential role of the intestinal microbiota in the well-functioning of host immunity necessitates the investigation of species-specific impacts on this interplay. Aim of this study was to examine the ability of defined Gram-positive and Gram-negative intestinal commensal bacterial species, namel...

Full description

Bibliographic Details
Main Authors: Ira Ekmekciu, Eliane von Klitzing, Christian Neumann, Petra Bacher, Alexander Scheffold, Stefan Bereswill, Markus M. Heimesaat
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2017.02430/full
id doaj-9f570a6a5e1641588b16f6ff8469aeec
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ira Ekmekciu
Eliane von Klitzing
Christian Neumann
Christian Neumann
Petra Bacher
Alexander Scheffold
Alexander Scheffold
Stefan Bereswill
Markus M. Heimesaat
spellingShingle Ira Ekmekciu
Eliane von Klitzing
Christian Neumann
Christian Neumann
Petra Bacher
Alexander Scheffold
Alexander Scheffold
Stefan Bereswill
Markus M. Heimesaat
Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment
Frontiers in Microbiology
commensal intestinal microbiota
Escherichia coli
Lactobacillus johnsonii
fecal microbiota transplantation
secondary abiotic (gnotobiotic) mice
intestinal mucosal and peripheral and central immunity
author_facet Ira Ekmekciu
Eliane von Klitzing
Christian Neumann
Christian Neumann
Petra Bacher
Alexander Scheffold
Alexander Scheffold
Stefan Bereswill
Markus M. Heimesaat
author_sort Ira Ekmekciu
title Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment
title_short Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment
title_full Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment
title_fullStr Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment
title_full_unstemmed Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment
title_sort fecal microbiota transplantation, commensal escherichia coli and lactobacillus johnsonii strains differentially restore intestinal and systemic adaptive immune cell populations following broad-spectrum antibiotic treatment
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2017-12-01
description The essential role of the intestinal microbiota in the well-functioning of host immunity necessitates the investigation of species-specific impacts on this interplay. Aim of this study was to examine the ability of defined Gram-positive and Gram-negative intestinal commensal bacterial species, namely Escherichia coli and Lactobacillus johnsonii, respectively, to restore immune functions in mice that were immunosuppressed by antibiotics-induced microbiota depletion. Conventional mice were subjected to broad-spectrum antibiotic treatment for 8 weeks and perorally reassociated with E. coli, L. johnsonii or with a complex murine microbiota by fecal microbiota transplantation (FMT). Analyses at days (d) 7 and 28 revealed that immune cell populations in the small and large intestines, mesenteric lymph nodes and spleens of mice were decreased after antibiotic treatment but were completely or at least partially restored upon FMT or by recolonization with the respective bacterial species. Remarkably, L. johnsonii recolonization resulted in the highest CD4+ and CD8+ cell numbers in the small intestine and spleen, whereas neither of the commensal species could stably restore those cell populations in the colon until d28. Meanwhile less efficient than FMT, both species increased the frequencies of regulatory T cells and activated dendritic cells and completely restored intestinal memory/effector T cell populations at d28. Furthermore, recolonization with either single species maintained pro- and anti-inflammatory immune functions in parallel. However, FMT could most effectively recover the decreased frequencies of cytokine producing CD4+ lymphocytes in mucosal and systemic compartments. E. coli recolonization increased the production of cytokines such as TNF, IFN-γ, IL-17, and IL-22, particularly in the small intestine. Conversely, only L. johnsonii recolonization maintained colonic IL-10 production. In summary, FMT appears to be most efficient in the restoration of antibiotics-induced collateral damages to the immune system. However, defined intestinal commensals such as E. coli and L. johnsonii have the potential to restore individual functions of intestinal and systemic immunity. In conclusion, our data provide novel insights into the distinct role of individual commensal bacteria in maintaining immune functions during/following dysbiosis induced by antibiotic therapy thereby shaping host immunity and might thus open novel therapeutical avenues in conditions of perturbed microbiota composition.
topic commensal intestinal microbiota
Escherichia coli
Lactobacillus johnsonii
fecal microbiota transplantation
secondary abiotic (gnotobiotic) mice
intestinal mucosal and peripheral and central immunity
url http://journal.frontiersin.org/article/10.3389/fmicb.2017.02430/full
work_keys_str_mv AT iraekmekciu fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT elianevonklitzing fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT christianneumann fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT christianneumann fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT petrabacher fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT alexanderscheffold fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT alexanderscheffold fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT stefanbereswill fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
AT markusmheimesaat fecalmicrobiotatransplantationcommensalescherichiacoliandlactobacillusjohnsoniistrainsdifferentiallyrestoreintestinalandsystemicadaptiveimmunecellpopulationsfollowingbroadspectrumantibiotictreatment
_version_ 1725745224689385472
spelling doaj-9f570a6a5e1641588b16f6ff8469aeec2020-11-24T22:29:01ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2017-12-01810.3389/fmicb.2017.02430306635Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic TreatmentIra Ekmekciu0Eliane von Klitzing1Christian Neumann2Christian Neumann3Petra Bacher4Alexander Scheffold5Alexander Scheffold6Stefan Bereswill7Markus M. Heimesaat8Intestinal Microbiology Research Group, Institute of Microbiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyIntestinal Microbiology Research Group, Institute of Microbiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyDepartment of Cellular Immunology, Clinic for Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyGerman Rheumatism Research Center, Leibniz Association, Berlin, GermanyDepartment of Cellular Immunology, Clinic for Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyDepartment of Cellular Immunology, Clinic for Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyGerman Rheumatism Research Center, Leibniz Association, Berlin, GermanyIntestinal Microbiology Research Group, Institute of Microbiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyIntestinal Microbiology Research Group, Institute of Microbiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyThe essential role of the intestinal microbiota in the well-functioning of host immunity necessitates the investigation of species-specific impacts on this interplay. Aim of this study was to examine the ability of defined Gram-positive and Gram-negative intestinal commensal bacterial species, namely Escherichia coli and Lactobacillus johnsonii, respectively, to restore immune functions in mice that were immunosuppressed by antibiotics-induced microbiota depletion. Conventional mice were subjected to broad-spectrum antibiotic treatment for 8 weeks and perorally reassociated with E. coli, L. johnsonii or with a complex murine microbiota by fecal microbiota transplantation (FMT). Analyses at days (d) 7 and 28 revealed that immune cell populations in the small and large intestines, mesenteric lymph nodes and spleens of mice were decreased after antibiotic treatment but were completely or at least partially restored upon FMT or by recolonization with the respective bacterial species. Remarkably, L. johnsonii recolonization resulted in the highest CD4+ and CD8+ cell numbers in the small intestine and spleen, whereas neither of the commensal species could stably restore those cell populations in the colon until d28. Meanwhile less efficient than FMT, both species increased the frequencies of regulatory T cells and activated dendritic cells and completely restored intestinal memory/effector T cell populations at d28. Furthermore, recolonization with either single species maintained pro- and anti-inflammatory immune functions in parallel. However, FMT could most effectively recover the decreased frequencies of cytokine producing CD4+ lymphocytes in mucosal and systemic compartments. E. coli recolonization increased the production of cytokines such as TNF, IFN-γ, IL-17, and IL-22, particularly in the small intestine. Conversely, only L. johnsonii recolonization maintained colonic IL-10 production. In summary, FMT appears to be most efficient in the restoration of antibiotics-induced collateral damages to the immune system. However, defined intestinal commensals such as E. coli and L. johnsonii have the potential to restore individual functions of intestinal and systemic immunity. In conclusion, our data provide novel insights into the distinct role of individual commensal bacteria in maintaining immune functions during/following dysbiosis induced by antibiotic therapy thereby shaping host immunity and might thus open novel therapeutical avenues in conditions of perturbed microbiota composition.http://journal.frontiersin.org/article/10.3389/fmicb.2017.02430/fullcommensal intestinal microbiotaEscherichia coliLactobacillus johnsoniifecal microbiota transplantationsecondary abiotic (gnotobiotic) miceintestinal mucosal and peripheral and central immunity